Moderna | MRNA - Assets


Moderna reported $13.47B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Acadia Pharmaceuticals USD 1.79B 51.25M Sep/2026
Agios Pharmaceuticals USD 1.06B 44.38M Sep/2026
Alnylam Pharmaceuticals USD 7.99B 2.44B Sep/2026
Amgen USD 96.05B 409M Sep/2026
Arrowhead Research USD 2.11B 156.25M Jun/2026
Biogen USD 32.05B 32.5M Sep/2026
BioMarin Pharmaceutical USD 11.57B 154.21M Sep/2026
Celltrion KRW 779.18B 10.37B Jun/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.28B 62.98M Sep/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Gilead Sciences USD 51.41B 2.05B Sep/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
Incyte USD 7.29B 585.39M Sep/2026
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
Kangmei Pharma CNY 13.07B 239.31M Jun/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Moderna USD 13.47B 2.51B Sep/2026
Organigram Holdings CAD 820.26M 298.95M Jun/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pharma Mar EUR 408.4M 14.8M Sep/2026
Puma Biotechnology USD 202.86M 7.95M Sep/2025
Qiagen NV USD 5.89B 107.14M Jun/2026
Regeneron Pharmaceuticals USD 44.41B 2.67B Sep/2026
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sarepta Therapeutics USD 3.17B 22.45M Sep/2026
Sartorius EUR 9.67B 70.9M Sep/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tilray USD 2.1B 15.95M Sep/2025
Ultragenyx Pharmaceutical USD 1.19B 77M Sep/2026
United Therapeutics USD 7.03B 186M Sep/2026
Vertex Pharmaceuticals USD 32.74B 5.31B Sep/2026
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 17.71B 799.05M Sep/2026